Juliette Gay

618 total citations
19 papers, 423 citations indexed

About

Juliette Gay is a scholar working on Hematology, Oncology and Genetics. According to data from OpenAlex, Juliette Gay has authored 19 papers receiving a total of 423 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Hematology, 5 papers in Oncology and 4 papers in Genetics. Recurrent topics in Juliette Gay's work include Estrogen and related hormone effects (3 papers), Breast Cancer Treatment Studies (3 papers) and Cerebral Venous Sinus Thrombosis (2 papers). Juliette Gay is often cited by papers focused on Estrogen and related hormone effects (3 papers), Breast Cancer Treatment Studies (3 papers) and Cerebral Venous Sinus Thrombosis (2 papers). Juliette Gay collaborates with scholars based in France, United States and Switzerland. Juliette Gay's co-authors include Laurent Peyrin‐Biroulet, Mathias Chamaillard, Luís Antunes, Florent Gonzalez, Jean‐Frédéric Colombel, Christel Neut, Pierre Desreumaux, David T. Kiang, Anne I. Goldman and B. J. Kennedy and has published in prestigious journals such as New England Journal of Medicine, SHILAP Revista de lepidopterología and Cancer.

In The Last Decade

Juliette Gay

17 papers receiving 409 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Juliette Gay France 10 159 133 103 79 64 19 423
Kumi Ishida Japan 11 90 0.6× 74 0.6× 62 0.6× 134 1.7× 50 0.8× 31 343
Ken Kawakami Japan 13 89 0.6× 102 0.8× 213 2.1× 225 2.8× 75 1.2× 49 554
Ia Pantsulaia Georgia 14 38 0.2× 93 0.7× 93 0.9× 41 0.5× 169 2.6× 42 480
Qingsong Tao China 12 89 0.6× 74 0.6× 56 0.5× 147 1.9× 153 2.4× 30 464
Lea I. Kredel Germany 8 221 1.4× 173 1.3× 46 0.4× 100 1.3× 100 1.6× 12 478
M Brüwer Germany 10 116 0.7× 59 0.4× 81 0.8× 146 1.8× 89 1.4× 25 405
Tasneem Ahmed United States 9 101 0.6× 65 0.5× 78 0.8× 145 1.8× 142 2.2× 18 468
Dolores López-Maderuelo Spain 7 37 0.2× 221 1.7× 65 0.6× 72 0.9× 115 1.8× 11 514
H Tateishi Japan 8 169 1.1× 102 0.8× 144 1.4× 98 1.2× 97 1.5× 19 510
Jens Hämling Germany 8 251 1.6× 129 1.0× 27 0.3× 110 1.4× 56 0.9× 9 448

Countries citing papers authored by Juliette Gay

Since Specialization
Citations

This map shows the geographic impact of Juliette Gay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Juliette Gay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Juliette Gay more than expected).

Fields of papers citing papers by Juliette Gay

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Juliette Gay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Juliette Gay. The network helps show where Juliette Gay may publish in the future.

Co-authorship network of co-authors of Juliette Gay

This figure shows the co-authorship network connecting the top 25 collaborators of Juliette Gay. A scholar is included among the top collaborators of Juliette Gay based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Juliette Gay. Juliette Gay is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Andrieu‐Ponel, Valérie, et al.. (2024). Massive circulating metastatic cells: A case of carcinocythemia. SHILAP Revista de lepidopterología. 12(2). e8471–e8471. 2 indexed citations
2.
Loyau, Stéphane, Dorothée Faille, Juliette Gay, et al.. (2024). Impaired fibrinolysis in JAK2V617F-related myeloproliferative neoplasms. Journal of Thrombosis and Haemostasis. 22(11). 3199–3208. 1 indexed citations
3.
Gay, Juliette, Richard Chocron, Fanny Bajolle, et al.. (2023). Heparin-induced thrombocytopenia in newborns: experience at a pediatric hospital and a literature review. Research and Practice in Thrombosis and Haemostasis. 7(7). 102214–102214.
4.
Gay, Juliette, et al.. (2022). State of the art in cerebral venous sinus thrombosis animal models. Journal of Thrombosis and Haemostasis. 20(10). 2187–2196. 6 indexed citations
5.
Friedrich, Chloé, Juliette Gay, Marie Templé, et al.. (2022). PCR‐Fluo‐ASXL1‐FA: A fast, sensitive and inexpensive complementary method to detect ASXL1 mutations in haematological malignancies. International Journal of Laboratory Hematology. 44(5). 928–933.
6.
Loyau, Stéphane, Sandro Benichi, Juliette Gay, et al.. (2021). A Novel Mouse Model for Cerebral Venous Sinus Thrombosis. Translational Stroke Research. 12(6). 1055–1066. 7 indexed citations
7.
Gay, Juliette, Nicolas Gendron, Marie‐Laure Dardé, et al.. (2019). Disseminated toxoplasmosis associated with hemophagocytic syndrome after kidney transplantation: A case report and review. Transplant Infectious Disease. 21(5). e13154–e13154. 13 indexed citations
8.
Gay, Juliette, et al.. (2019). Lupus anticoagulant diagnosis in patients receiving direct oral FXa inhibitors at trough levels: A real‐life study. International Journal of Laboratory Hematology. 41(6). 738–744. 13 indexed citations
9.
Gendron, Nicolas, et al.. (2018). Usefulness of initial plasma dabigatran concentration to predict rebound after reversal. Haematologica. 103(5). e226–e229. 15 indexed citations
10.
Giuliani, Meredith, Lorna Sampson, O Wong, et al.. (2016). Prognostic Value of Pretreatment Circulating Neutrophils, Monocytes, and Lymphocytes on Outcomes in Lung Stereotactic Body Radiotherapy. Current Oncology. 23(4). 362–368. 15 indexed citations
12.
Gay, Juliette, et al.. (2012). PCN87 Cost Effectiveness Evaluation of Vemurafenib, an Orphan Drug for Braf Mutant Metastatic Melanoma. Value in Health. 15(7). A425–A425. 2 indexed citations
13.
Torkelson, Carolyn J., Erin Sweet, Mark R. Martzen, et al.. (2012). Phase 1 Clinical Trial of Trametes versicolor in Women with Breast Cancer. SHILAP Revista de lepidopterología. 2012. 1–7. 52 indexed citations
14.
Peyrin‐Biroulet, Laurent, Mathias Chamaillard, Florent Gonzalez, et al.. (2006). Mesenteric fat in Crohn’s disease: a pathogenetic hallmark or an innocent bystander?. Gut. 56(4). 577–583. 203 indexed citations
15.
Tans-Kersten, Julie, Juliette Gay, & Caitilyn Allen. (2000). Ralstonia solanacearum AmpD is required for wild‐type bacterial wilt virulence. Molecular Plant Pathology. 1(3). 179–185. 10 indexed citations
16.
Kiang, David T., Juliette Gay, Anne I. Goldman, & B. J. Kennedy. (1985). A Randomized Trial of Chemotherapy and Hormonal Therapy in Advanced Breast Cancer. New England Journal of Medicine. 313(20). 1241–1246. 37 indexed citations
17.
Kiang, David T., et al.. (1981). Combination therapy of hormone and cytotoxic agents in advanced breast cancer. Cancer. 47(3). 452–456. 16 indexed citations
18.
Kiang, David T., et al.. (1980). Estrogen receptor status and response to chemotherapy in advanced breast cancer. Cancer. 46(S12). 2814–2817. 20 indexed citations
19.
Gay, Juliette, et al.. (1976). A Double-Blind Comparative Clinical Trial of Floctafenine and Four Other Analgesics Conducted in General Practice. Journal of International Medical Research. 4(3). 179–182. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026